BIRC5 and ovarian neoplasm: Thus, targeting BIRC5 by using small molecule inhibitors like YM155 may provide a novel therapeutic approach in ovarian cancer therapy by inhibiting ovarian tumor metastasis and overcoming chemoresistance.